SAN DIEGO, March 3 /PRNewswire-FirstCall/ -- Sequenom, Inc. today announced that Harry F. Hixson, PhD, chairman and interim CEO, will present an overview of the company at the following conferences in March.
A live webcast and 30-day archive of these presentations will be available at http://ir.sequenom.com.
About Sequenom
Sequenom, Inc. is a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions. Sequenom develops innovative technology, products and diagnostic tests that target and serve discovery and clinical research, and molecular diagnostics markets. The company was founded in 1994 and is headquartered in San Diego, California. Sequenom maintains a Web site at http://www.sequenom.com to which Sequenom regularly posts copies of its press releases as well as additional information about Sequenom. Interested persons can subscribe on the Sequenom Web site to email alerts or RSS feeds that are sent automatically when Sequenom issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the Web site.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040415/SQNMLOGO)
CONTACT: Ian Clements, PhD, Sr. Director, Corp. Communications of
Sequenom, Inc., +1-858-202-9000; or Investor Relations, Jody Cain of
Lippert/Heilshorn & Associates, +1-310-691-7100, jcain@lhai.com; or Media
Relations, Dan Budwick of Pure Communications, +1-973-271-6085, both for
Sequenom, Inc.
Web site: http://www.sequenom.com/
